Idexx Laboratories | IDXX - Assets


Idexx Laboratories reported $3.39B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Accuray USD 448.01M 8.81M Dec/2025
Align Technology USD 6.31B 80.48M Mar/2026
AngioDynamics USD 269.68M 4.04M Sep/2025
Dentsply International USD 5.23B 200M Mar/2026
Dexcom USD 6.63B 293.4M Mar/2026
Edwards Lifesciences USD 13.32B 376M Mar/2026
Fujifilm JPY 6.05T 170.69B Mar/2026
Globus Medical USD 5.44B 136.79M Mar/2026
Henry Schein USD 11.3B 89M Mar/2026
Idexx Laboratories USD 3.39B 34.74M Mar/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 2.99B 203.2M Mar/2026
Integra LifeSciences USD 3.58B 24.28M Mar/2026
Intuitive Surgical USD 20.11B 347.7M Mar/2026
Masimo USD 1.64B 56.2M Mar/2026
Neogen USD 3.36B 953K Dec/2025
Orthofix International USD 886.6M 35.95M Mar/2026
Phibro Animal Health USD 1.45B 39.56M Mar/2026
ResMed USD 8.78B 280.91M Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
Steris USD 10.74B 145.8M Mar/2026
Tandem Diabetes Care USD 1.15B 272.28M Mar/2026
Teleflex USD 6.78B 164.24M Mar/2026
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Zoetis USD 15.15B 313M Mar/2026